Stocks to watch: LIC, IndiGo, GSK Pharma, Max Health, PSU, Bharat Forge
Stocks to watch today: The Sensex and Nifty are looking to start Tuesday’s session on a dismal note as global sentiment remains muted. As of 7:30 a.m., SGX Nifty futures were trading at 15,890 levels, hinting at an opening gain of 40-50 odd points for the Nifty. That aside, the debut in the LIC market will be in focus today. Investors will also be keeping a close eye on the Wholesale Price Index (WPI) reading for April, which will be announced later today. In the meantime, here are the stocks to watch in trading today:
4th Quarter Revenues: Bharti Airtel, Indian Oil Corporation, DLF, PI Industries, Abbott India, Bajaj Electricals, Bajaj Healthcare, EID Parry (India), Indoco Remedies, IRB Infrastructure Developers, Jubilant Ingrevia, Kajaria Ceramics, Dr Lal PathLabs, Minda Corporation, Sapphire Foods India , Fairchem Organics, Galaxy Surfactants, GMR Infrastructure, NOCIL, Nucleus Software Exports, Sun Pharma Advanced Research Company and Zydus Wellness will be in focus ahead of their fourth quarter results today.
LIC: The state-owned insurance giant will go public today. LIC’s shares were trading at a discount of 15 to 20 rupees per coin from its issue price of 949 rupees on the gray market before its listing. Read here
PSU Actions and Insurance: Shares of UAPs and insurance companies will also be in focus ahead of LIC’s listing today.
Indigo: The DGCA aviation regulator has found the company’s treatment of a special child to be inappropriate. The company said it received communications from the DGCA about the handling of a special child at Ranchi Airport. The DGCA will issue a show cause notice to Indigo to explain itself.
Airlines companies: Jet fuel prices rose 5.3% on Monday – the tenth straight increase this year – to a record high, in line with a surge in global energy prices. Airlines will be the focus of attention, as jet fuel accounts for the majority of their input costs.
GlaxoSmithKline Pharmaceuticals: The company reported a consolidated net loss of Rs 55 crore from continuing operations for the March quarter (Q4FY22). The pharmaceutical company had reported a net profit of Rs 4 crore for Q4FY21. Operating revenue reached Rs 810 crore for the fourth quarter from Rs 744 crore a year ago.
Bharat’s Forge: The auto components major reported a 9.3% increase in its consolidated net profit to Rs 231.86 crore in the fourth quarter ended March 2022, on the back of an increase in revenue. The company had posted a consolidated net profit of Rs 212.12 crore in the same period last year. Read here
Capital Aditya Birla: The company said an independent committee investigating a whistleblower complaint found no basis for the allegations against Aditya Birla Sun Life and its employees. He added that the complaint did not contain allegations against CEO Ajay Srinivasan.
Srinivasan had expressed interest in taking on a new role within the group, which led to him stepping down as CEO of Aditya Birla Capital.
Raymond: The company reported a profit of Rs 265 crore in the March quarter against Rs 59 crore a year ago. Revenue for the quarter rose 44% year-on-year to Rs 1,958 crore. EBITDA increased by 84% year-on-year to Rs 285 crore.
VIP Industries: The company reported a profit of Rs 12 crore in the March quarter compared to a loss of Rs 4 crore a year ago. Revenue for the quarter stood at Rs 356 crore compared to Rs 243 crore last year. EBITDA was Rs 33 crore versus Rs 3 crore.
Max Health: The hospital chain has approved the merger of its 100% subsidiaries – Alps Hospital and Max Hospitals. The company said the program is subject to necessary legal and regulatory approvals.
Kajaria ceramics: The company said it has started commercial production of ceramic floor tiles and vitrified tiles at manufacturing plants in Gailpur, Rajasthan, and Chittoor, Andhra Pradesh. Rajasthan plant capacity increased to 4.2 MSM per year for ceramic floor tiles, while Chittoor plant capacity increased to 3.8 MSM per year for vitrified tile manufacturing .
SJVN: The company will develop another Arun-4 hydropower project worth Rs 4,900 crore in Nepal. A memorandum of understanding for the development of the 490 MW Arun-4 hydropower project in Nepal was signed in Lumbini, Nepal, in the presence of Prime Minister Narendra Modi and Nepalese Prime Minister Sher Bahadur Deuba, the company announced in a statement.
KEC International: The company has won orders worth Rs 1150 crore in its various businesses. The company said the various orders in the civil business further strengthen the diversification of our portfolio and reaffirm our confidence that this business will continue to grow strongly in the future.
Infra IRB: The company said its gross toll collections in April stood at Rs 327 crore compared to Rs 306.66 crore in March. Gross toll collections in April last year were Rs 196.64 crore. The company said on April 21 that toll collection had been suspended due to unrest from farmers.
India Steel Exchange: The company’s board has approved a plan to raise up to Rs 600 crore through rights issue or FPO. In addition, the board also approved a stock split at a ratio of 1:10.
Stocks under F&O prohibition: GNFC, PNB and Indiabulls Housing Finance are on F&O bans today.